ロード中...
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
Background: The search for a biomarker of Alzheimer’s disease (AD) pathology (amyloid-β (Aβ) and tau) is ongoing, with the best markers currently being measurements of Aβ and tau in cerebrospinal fluid (CSF) and via positron emission tomography (PET) scanning. These methods are relatively invasive,...
保存先:
| 出版年: | J Alzheimers Dis |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
IOS Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5181674/ https://ncbi.nlm.nih.gov/pubmed/27834776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-160707 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|